[1] COHEN P A,JHINGRAN A,OAKNIN A,et al. Cervical cancer[J].Lancet,2019,393(10167):169-182.
[2] YI Y,LIU Y,WU W,et al. Reconstruction and analysis of circRNA miRNA mRNA network in the pathology of cervical cancer[J]. Oncol Rep,2019,41(4):2209-2225.
[3] ZHENG L,LI T,ZHANG Y,et al. Oncogene ATAD2 promotes cell proliferation,invasion and migration in cervical cancer[J]. Oncol Rep,2015,33(5):2337-2344.
[4] THADANI R,KAMENZ J,HEEGER S,et al. Cell-cycle regulation of dynamic chromosome association of the condensin complex[J].Cell Rep,2018,23(8):2308-2317.
[5] PALOU R,DHANARAMAN T,MARRAKCHI R,et al. Condensin ATPase motifs contribute differentially to the maintenance of chromosome morphology and genome stability[J]. PLoS Biol,2018,16(6):e2003980.
[6] HUANG K,JIA J,WU C,et al. Ribosomal RNA gene transcription mediated by the master genome regulator protein CCCTC-binding factor (CTCF) is negatively regulated by the condensin complex[J]. J Biol Chem,2013,288(36):26067-26077.
[7] ZHAO SG,EVANS JR,KOTHARI V,et al. The landscape of prognostic outlier genes in high-risk prostate cancer[J]. Clin Cancer Res,2016,22(7):1777-1786.
[8] WANG Z,SONG Y,LI S,et al. DNA polymerase theta(POLQ) is important for repair of DNA double-strand breaks caused by fork collapse[J]. J Biol Chem,2019,294(11):3909-3919.
[9] HONEGGER A,SCHILLING D,BASTIAN S,et al. Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells[J]. PLoS Pathog,2015,1(3):e1004712.
[10] LIU X. Up-regulation of miR-20a by HPV16 E6 exerts growth-promoting effects by targeting PDCD6 in cervical carcinoma cells[J].Biomed Pharmacother,2018,102:996-1002.
[11] ZHENG Z M,WANG X. Regulation of cellular miRNA expression by human papillomaviruses[J]. Biochim Biophys Acta,2011,1809(11/12):668-677.
[12] CHENG Y,GUO Y,ZHANG Y,et al. MicroRNA-106b is involved in transforming growth factor beta1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma[J]. J Exp Clin Cancer Res,2016,35:11.
[13] LI M Y,HU X X. Meta-analysis of microRNA expression profiling studies in human cervical cancer[J]. Med Oncol,2015,32(6):510.
[14] MA D,ZHANG Y Y,GUO Y L,et al. Profiling of microRNA-mRNA reveals roles of microRNAs in cervical cancer[J]. Chin Med J(Engl),2012,125(23):4270-4276
[15] KANG H W,WANG F,WEI Q,et al. miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells[J].FEBS Lett,2012,586(6):897-904.
[16] XIONG Y,SUN F,DONG P,et al. iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling[J]. J Exp Clin Cancer Res,2017,36(1):48.
[17] ZHAO S,YAO D,CHEN J,et al. MiR-20a promotes cervical cancer proliferation and metastasis in vitro and in vivo[J]. PLoS One,2015,
10(3):e0120905.
[18] ZHOU Q,DONG J,LUO R,et al. MicroRNA-20a regulates cell proliferation,apoptosis and autophagy by targeting thrombospondin 2 in cervical cancer[J]. Eur J Pharmacol,2019,844:102-109.
[19] ZHU S Y,WU Q Y,ZHANG C X,et al. miR-20a inhibits the killing effect of natural killer cells to cervical cancer cells by downregulating RUNX1[J]. Biochem Biophys Res Commun,2018,505(1):309-316.
[20] CAI N,HU L,XIE Y,et al. MiR-17-5p promotes cervical cancer cell proliferation and metastasis by targeting transforming growth factor-beta receptor 2[J]. Eur Rev Med Pharmacol Sci,2018,22(7):1899-1906.
[1]李晶晶,赵卫东,王德华.72例宫颈癌术后并发症及卵巢功能分析[J].天津医科大学学报,2014,20(01):63.
[2]崔丽阳,岳天孚.高危型HPV持续感染的影响因素探讨[J].天津医科大学学报,2014,20(03):209.
CUI Li-yang,YUE Tian-fu.Investigation on factors for persistent high-risk human papilloma virus infection[J].Journal of Tianjin Medical University,2014,20(01):209.
[3]孙 艳,齐 政,王德华,等.miR-186通过靶定CEA抑制宫颈癌细胞转移[J].天津医科大学学报,2016,22(04):288.
SUN Yan,QI Zheng,WANG De-hua,et al.miR-186 inhibits cervical cancer migration by targetting CEA[J].Journal of Tianjin Medical University,2016,22(01):288.
[4]李 娜,李洪林,尹利荣.HPV E6/E7 mRNA与YAP在宫颈癌中的表达与相关性研究[J].天津医科大学学报,2018,24(04):307.
LI Na,LI Hong-lin,YIN Li-rong.HPV E6/E7 mRNA and YAP expression and their correlation in cervical carcinoma[J].Journal of Tianjin Medical University,2018,24(01):307.
[5]曲首辉,鲍志敏,刘荣欣.TCT、活检病理在宫颈上皮瘤变及早期宫颈癌诊断中的价值分析[J].天津医科大学学报,2018,24(04):360.
[6]陈 辉,樊茹佳,丁继侠.宫颈癌组织中Foxm1、ANGPTL4蛋白表达及临床意义[J].天津医科大学学报,2019,25(05):510.
CHEN Hui,FAN Ru-jia,DING Ji-xia.Expression and clinical significance of Foxm1 and ANGPTL4 protein in cervical cancer tissues[J].Journal of Tianjin Medical University,2019,25(01):510.
[7]闫晓芳,谢 虹,汤 华.miR-3685通过靶向CTTN抑制宫颈癌细胞的迁移、侵袭及生长[J].天津医科大学学报,2020,26(01):8.
YAN Xiao-fang,XIE Hong,TANG Hua.miR-3685 inhibits migration, invasion and growth of cervical cancer cells by targeting CTTN[J].Journal of Tianjin Medical University,2020,26(01):8.
[8]白丽丽,汤华.TNF-α诱导的circMAN1A2促进宫颈癌细胞的迁移、侵袭和增殖[J].天津医科大学学报,2020,26(02):103.
BAI Li-li,TANG Hua.TNF-α-induced circMAN1A2 promotes migration, invasion and proliferation of cervical cancer cells[J].Journal of Tianjin Medical University,2020,26(01):103.
[9]赵敬,杨金豪,张文帆,等.2009—2020年中国女性生殖道支原体、衣原体和人乳头瘤病毒感染与宫颈癌发生相关性的Meta分析[J].天津医科大学学报,2021,27(04):396.
ZHAO Jing,YANG Jin-hao,ZHANG Wen-fan,et al.A meta-analysis of association between Mycoplasma,Chlamydia infection and Human papillomavirus infection in female genital tract and cervical cancer in China from 2009 to 2020[J].Journal of Tianjin Medical University,2021,27(01):396.
[10]赵敬,杨金豪 综述,常艳敏,等.中国宫颈癌DNA甲基化标志物的研究进展[J].天津医科大学学报,2021,27(05):545.